Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$37.94 USD

37.94
696,157

-1.48 (-3.75%)

Updated Oct 31, 2024 04:00 PM ET

After-Market: $37.95 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient monitoring.

Here's Why You Should Hold on to CONMED (CNMD) Stock Now

CONMED (CNMD) continues to gain momentum from a solid product portfolio and strong General Surgery business. However, data security threats linger.

Teleflex (TFX) Hurt by Urolift Cancellations, Cost Woes

Teleflex (TFX) continues to face supply-chain challenges and freight logistic delays.

Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

STERIS (STE) Strategic Buyouts Aid Growth, Margin Woe Stays

STERIS' (STE) significant revenues from acquisitions of Key Surgical and Cantel Medical appear promising.

Cardiovascular Systems (CSII) Finances New DCB Development

Per the terms of the deal, Cardiovascular Systems (CSII) is providing milestone-based financing to CVT for the development of coronary and peripheral DCBs.

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Medtronic (MDT) Inks Deal to Offer Touch Surgery Enterprise

Medtronic's (MDT) Touch Surgery Enterprise gives surgical teams a powerful new tool to enhance patient care by simplifying the process to capture and analyze surgical videos.

Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock.

Nevro's (NVRO) PDN Therapy Gets Noridian's Medicare Coverage

Latest favorable coverage decision for Nevro's (NVRO) PDN Therapy by Noridian is expected to allow the former to serve a wider patient pool.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

Accuray's (ARAY) CyberKnife S7 System Gets Chosen by CARTI

Accuray's (ARAY) CyberKnife S7 System gets selected by the CARTI medical care team, thereby offering better cancer care in Arkansas via expanded access to advanced technology.

Here's Why You Should Retain Charles River (CRL) Stock For Now

Investors are optimistic about Charles River (CRL) on robust demand in Biologics Testing Solutions and Microbial Solutions businesses.

Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?

Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.

Here's Why You Should Retain West Pharmaceutical (WST) Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

Merit Medical's (MMSI) Product Included in FDA's Program

Receipt of the Breakthrough Device Designation for Merit Medical's (MMSI) Embosphere Microspheres is expected to improve patient outcome.

Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp

Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

PacBio (PACB) Supports SickKids With Sequencing Technology

PacBio (PACB) to help SickKids in detecting potential genetic causes of a range of medical and developmental conditions.

Zacks.com featured highlights include AutoNation, Asbury Automotive Group, AMN Healthcare Services, Teck Resources and AGCO

AutoNation, Asbury Automotive Group, AMN Healthcare Services, Teck Resources and AGCO are included in this blog.

AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

Catalent's (CTLT) New Tie-Up to Provide Better Patient Access

Catalent's (CTLT) latest collaboration is expected to enable it to provide customers access to the TFF technology.

Chemed (CHE) Roto-Rooter Sales Robust Despite COVID-19 Woes

Chemed's (CHE) Roto-Rooter business gains from growing demand for plumbing, drain cleaning and excavation and water restoration services.

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now

Investors are optimistic about Bio-Rad (BIO) on solid recovery in most of its key global markets as well as an uptick in demand for COVID-related products.

Dexcom's (DXCM) CGM Gets FDA's Breakthrough Device Designation

Dexcom's (DXCM) CGM's use in the hospital setting is likely to be more effective in glycemic management and improved patient outcomes.